EpitoGenesis, Inc. is organized around design and develop all natural efficacious immune enhancing adjuvants and delivery systems for prophylactic and therapeutic vaccines with strong emphasis on safety. A primary objective is to eliminate vaccination side effects such as site of injection pain and swelling, fever, Focused on development of immune enhancing adjuvants and delivery systems for prophylactic and therapeutic vaccines as well as robust and rapid vaccine manufacturing platforms, the firm's vaccine immune-enhancing delivery systems will aim to reduce the number of doses, the concentration of each dose, as well as provide the ability to administer the vaccines in a needle-free manner either mucosally or transcutaneously. These will clearly improve the health of various segments of the population, particularly the infant and the elderly. Also an area of focus is develoment of rapid, effective and inexpensive vaccine manufacturing platform technologies.
